News
GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...
Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...
Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...
The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...
Results from this study show that there is a direct correlation between the use of anti-obesity medications and testosterone levels,” the study author said.
A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...
Many breast cancer survivors experience cognitive impairment, difficulty concentrating, or memory loss during and after treatment. Despite the recognized link between mental cognition and breast ...
The Dementia Risk Reduction Library draws heavily from Dr. Darrow’s Amazon best-selling books, Preventing Decline: Advances in the Medical Treatment of Hearing Loss and Tinnitus and Stop Living ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a neurologist explains the connection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results